tirzepatide indications fda is FDA-approved for weight management, with clinical trials showing average weight loss of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting What is the FDA-approved indication

Clinical Evidence: GLP-1 Treatment for NAFLD in the UK Emerging clinical evidence suggests GLP-1 receptor agonists may offer therapeutic benefits for patients with NAFLD and NASH, though it is important to note that these medications are not currently licensed specifically for liver disease treatment in the UK

The undesired DKP side reactions during SPPS have been found to be particularly problematic with certain peptide sequences 35 and benzyl-type peptide resin linkages 4,6 and catalyzed by acidic or basic conditions

Nature 585 , 277282 (2020)

Not a medical necessity

Experimental Gerontology , 147 , 111263111272

History of weight loss surgery